WallStSmart

Medtronic PLC (MDT)vsProfusa, Inc. Common Stock (PFSA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MDT leads profitability with a 13.0% profit margin vs 0.0%. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

PFSA

Avoid

17

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 5.3
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for PFSA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

PFSA1 strengths · Avg: 10.0/10
Debt/EquityHealth
-0.6210/10

Conservative balance sheet, low leverage

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

PFSA4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$727,2603/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : PFSA

The strongest argument for PFSA centers on Debt/Equity.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : PFSA

The primary concerns for PFSA are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

MDT carries more volatility with a beta of 0.73 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDT scores higher overall (56/100 vs 17/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Profusa, Inc. Common Stock

HEALTHCARE · MEDICAL DEVICES · USA

Profusa, Inc. develops bioengineered sensors that are designed to become one with the body to detect and continuously transmit clinical -grade data for personal and medical use. The company is headquartered in Emeryville, California.

Visit Website →

Want to dig deeper into these stocks?